Logo image of TELO

TELOMIR PHARMACEUTICALS INC (TELO) Stock Price, Quote, News and Overview

NASDAQ:TELO - Nasdaq - US87975F1049 - Common Stock - Currency: USD

2.15  +0.14 (+6.97%)

After market: 2.16 +0.01 (+0.47%)

TELO Quote, Performance and Key Statistics

TELOMIR PHARMACEUTICALS INC

NASDAQ:TELO (6/6/2025, 8:00:01 PM)

After market: 2.16 +0.01 (+0.47%)

2.15

+0.14 (+6.97%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High8.4
52 Week Low1.87
Market Cap63.98M
Shares29.76M
Float19.59M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-11 2025-08-11
IPO02-09 2024-02-09


TELO short term performance overview.The bars show the price performance of TELO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

TELO long term performance overview.The bars show the price performance of TELO in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of TELO is 2.15 USD. In the past month the price decreased by -14.68%. In the past year, price decreased by -61.81%.

TELOMIR PHARMACEUTICALS INC / TELO Daily stock chart

TELO Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 55.95 729.65B
JNJ JOHNSON & JOHNSON 15.43 373.01B
NVO NOVO-NORDISK A/S-SPONS ADR 20.73 331.61B
NVS NOVARTIS AG-SPONSORED ADR 14.2 233.10B
AZN ASTRAZENECA PLC-SPONS ADR 16.56 225.96B
MRK MERCK & CO. INC. 10.14 198.30B
PFE PFIZER INC 7.27 132.75B
SNY SANOFI-ADR 11.34 122.83B
BMY BRISTOL-MYERS SQUIBB CO 6.6 98.52B
GSK GSK PLC-SPON ADR 9.24 83.58B
ZTS ZOETIS INC 28.27 75.76B
HLN HALEON PLC-ADR 22.14 49.84B

About TELO

Company Profile

TELO logo image Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The company is headquartered in Tampa, Florida and currently employs 0 full-time employees. The company went IPO on 2024-02-09. The firm is focused on the development of Telomir-1, a novel small molecule metal ion chelator and regulator designed to lengthen the DNA’s protective telomere caps, which are crucial in the aging process. Telomir 1 is being developed to protect stem cells by elongating and stimulating the telomeres to sustain self-renewal. Telomir-1 helps protect against age-related conditions, including Progeria (a rare genetic disorder that causes rapid aging in children), Wilson’s disease (a genetic disorder leading to toxic copper buildup in the body), and age-related macular degeneration (AMD), as well as Type 2 Diabetes, cancer, and Alzheimer’s disease. The company is exploring the potential of Telomir-1 with ongoing research in animals and then in humans. The company is focused on developing and commercializing TELOMIR-1, proposed to be dosed orally, with the aim of promoting longevity and enhancing overall quality of life.

Company Info

TELOMIR PHARMACEUTICALS INC

900 West Platt Street, Suite 200

Tampa FLORIDA US

Employees: 0

TELO Company Website

TELO Investor Relations

Phone: 18138642562

TELOMIR PHARMACEUTICALS INC / TELO FAQ

What is the stock price of TELOMIR PHARMACEUTICALS INC today?

The current stock price of TELO is 2.15 USD. The price increased by 6.97% in the last trading session.


What is the ticker symbol for TELOMIR PHARMACEUTICALS INC stock?

The exchange symbol of TELOMIR PHARMACEUTICALS INC is TELO and it is listed on the Nasdaq exchange.


On which exchange is TELO stock listed?

TELO stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for TELOMIR PHARMACEUTICALS INC stock?

null analysts have analysed TELO and the average price target is 15.56 USD. This implies a price increase of 623.49% is expected in the next year compared to the current price of 2.15. Check the TELOMIR PHARMACEUTICALS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is TELOMIR PHARMACEUTICALS INC worth?

TELOMIR PHARMACEUTICALS INC (TELO) has a market capitalization of 63.98M USD. This makes TELO a Micro Cap stock.


How many employees does TELOMIR PHARMACEUTICALS INC have?

TELOMIR PHARMACEUTICALS INC (TELO) currently has 0 employees.


What are the support and resistance levels for TELOMIR PHARMACEUTICALS INC (TELO) stock?

TELOMIR PHARMACEUTICALS INC (TELO) has a resistance level at 2.16. Check the full technical report for a detailed analysis of TELO support and resistance levels.


Should I buy TELOMIR PHARMACEUTICALS INC (TELO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does TELOMIR PHARMACEUTICALS INC (TELO) stock pay dividends?

TELO does not pay a dividend.


When does TELOMIR PHARMACEUTICALS INC (TELO) report earnings?

TELOMIR PHARMACEUTICALS INC (TELO) will report earnings on 2025-08-11.


What is the Price/Earnings (PE) ratio of TELOMIR PHARMACEUTICALS INC (TELO)?

TELOMIR PHARMACEUTICALS INC (TELO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.63).


What is the Short Interest ratio of TELOMIR PHARMACEUTICALS INC (TELO) stock?

The outstanding short interest for TELOMIR PHARMACEUTICALS INC (TELO) is 11.09% of its float. Check the ownership tab for more information on the TELO short interest.


TELO Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

TELO Financial Highlights

Over the last trailing twelve months TELO reported a non-GAAP Earnings per Share(EPS) of -0.63. The EPS increased by 8.26% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -3809.55%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%67.5%
Sales Q2Q%N/A
EPS 1Y (TTM)8.26%
Revenue 1Y (TTM)N/A

TELO Ownership and Analysts


Ownership
Inst Owners12.05%
Ins Owners11.55%
Short Float %11.09%
Short Ratio12.59
Analysts
AnalystsN/A
Price Target15.56 (623.72%)
EPS Next Y25.93%
Revenue Next YearN/A